Citadel Advisors’s GoHealth GOCO Stock Holding History

Citadel Advisors’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-246	Closed	-$3.28K	–	14895
2023 Q4	$3.28K	Hold	246	–	–	﹤0.01%	13611
2023 Q3	$3.56K	Hold	246	–	–	﹤0.01%	13570
2023 Q2	$4.85K	Buy	+246	New	+$3.86K	﹤0.01%	13561
2022 Q4	–	Sell	-4,480	Closed	-$24K	–	15088
2022 Q3	$24K	Sell	4,480 -693	-13%	-$5.22K	﹤0.01%	12000
2022 Q2	$46K	Sell	5,173 -407	-7%	-$4.73K	﹤0.01%	11986
2022 Q1	$99K	Sell	5,580 -2,400	-30%	-$74.7K	﹤0.01%	12291
2021 Q4	$454K	Sell	7,980 -8,973	-53%	-$599K	﹤0.01%	9934
2021 Q3	$1.28M	Buy	16,953 +14,173	+510%	+$1.5M	﹤0.01%	7500
2021 Q2	$467K	Sell	2,780 -4,453	-62%	-$780K	﹤0.01%	10196
2021 Q1	$1.27M	Buy	7,233 +2,053	+40%	+$414K	﹤0.01%	7512
2020 Q4	$1.06M	Buy	5,180 +4,000	+339%	+$743K	﹤0.01%	6689
2020 Q3	$231K	Buy	+1,180	New	+$284K	﹤0.01%	8587

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citadel Advisors's GOCO Position: Q2 2025 in Review

Citadel Advisors sold out of GoHealth (GOCO) in Q2 2025, closing a stake of 27,036 shares — an estimated $332K sold.

Citadel Advisors first reported a position in GOCO in Q3 2020 and held it in 15 quarters. The position peaked at $13M in Q1 2021. 55 funds tracked by Wall St. Rank hold GOCO as of Q2 2025.

Citadel Advisors reported no remaining GoHealth position as of Q2 2025 after selling out during the quarter.
Citadel Advisors sold 27,036 GoHealth shares in Q2 2025, an estimated $332K.
Citadel Advisors first reported a position in GoHealth in Q3 2020 and held it in 15 quarters.
Citadel Advisors's GoHealth position peaked at $13M in Q1 2021.
55 funds tracked by Wall St. Rank held GoHealth as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.